NCT01610310View on ClinicalTrials.gov

Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
HealthyMultiple Sclerosis
Interventions
DEVICE

BIIB017 (peginterferon beta-1a) Pre-filled syringe (PFS)

125 mcg of peginterferon beta-1a (BIIB017) subcutaneous injection (SC) administered by PFS once on either Day 1 or Day 22

DEVICE

BIIB017 (peginterferon beta-1a) Autoinjector

125 mcg of peginterferon beta-1a (BIIB017) subcutaneous injection (SC) administered by autoinjector once on either Day 1 or Day 22

Trial Locations (1)

Unknown

Research Site, Saint Paul

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY